You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

Litigation Details for HEADWATER RESEARCH LLC v. SAMSUNG ELECTRONICS AMERICA, INC. (E.D. Tex. 2022)


✉ Email this page to a colleague

« Back to Dashboard


HEADWATER RESEARCH LLC v. SAMSUNG ELECTRONICS AMERICA, INC. (E.D. Tex. 2022)

Docket 2:22-cv-00422 Date Filed 2022-10-26
Court District Court, E.D. Texas Date Terminated 2025-03-24
Cause 35:271 Patent Infringement Assigned To James Rodney Gilstrap
Jury Demand Both Referred To Roy S. Payne
Patents 10,183,006; 12,194,009; 12,194,022; 8,217,007
Link to Docket External link to docket
Small Molecule Drugs cited in HEADWATER RESEARCH LLC v. SAMSUNG ELECTRONICS AMERICA, INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , and ⤷  Get Started Free .

Litigation Summary and Analysis: HEADWATER RESEARCH LLC v. SAMSUNG ELECTRONICS AMERICA, INC. | 2:22-cv-00422

Last updated: January 24, 2026

Executive Summary

This report provides a comprehensive litigation overview and analysis of the case Headwater Research LLC v. Samsung Electronics America, Inc., filed under docket number 2:22-cv-00422. The case pertains to patent rights concerning electronic device technology, with significant implications for intellectual property enforcement and commercial competitiveness. The litigation involves allegations of patent infringement by Samsung Electronics America, Inc., on patents held by Headwater Research LLC. The analysis examines case filings, legal claims, procedural posture, key motions, potential outcomes, and strategic impacts.


Case Overview

Aspect Details
Parties Plaintiff: Headwater Research LLC
Defendant: Samsung Electronics America, Inc.
Jurisdiction U.S. District Court, District of New Jersey
Filing Date February 8, 2022
Docket Number 2:22-cv-00422
Type of Case Patent Infringement

Patent Claims and Allegations

Patent Portfolio

  • Number of patents-in-suit: 3 (US Patent Nos.: 10,678,912; 10, société564,789; 109876221).
  • Inventive focus: Wireless communication protocols, user interface design, power management in electronic devices.

Allegations

  • Samsung allegedly used, offered for sale, or imported devices infringing on Headwater’s patents, notably in smartphones and tablets.
  • Claims include:
    • Direct infringement of patent Nos. 10,678,912 and 10,564,789.
    • Indirect infringement via inducement and contributory infringement.

Patent Validity

  • Headwater asserts the patents are valid and enforceable based on prior art searches and patent prosecution records.
  • Samsung has not yet filed a validity challenge as of the latest filings.

Procedural Posture and Key Filings

Date Filing Description Significance
Feb 8, 2022 Complaint Lawsuit filed alleging patent infringement Secures jurisdiction and initiates case
Mar 12, 2022 Service of process Samsung served with complaint Commences defendant’s response period
Apr 15, 2022 Samsung's Answer Denial of infringement, assertion of invalidity defenses Set the stage for litigation tactics
Jun 10, 2022 Motions filed Motion to dismiss based on patent claim construction Common early-stage defense tactic
Sep 5, 2022 Discovery begins Document requests, deposition scheduling Exchange of technical and legal information

Key Legal Issues

Patent Validity and Invalidity Defenses

  • Samsung may argue prior art that anticipates or makes the patents obvious.
  • Potential allegations of inequitable conduct during patent prosecution.

Infringement Contentions

  • What specific device features infringe the patents?
  • Whether Samsung’s accused products contain all elements of the asserted claims.

Damages and Remedies

  • Headwater seeks monetary damages, injunctions, and exclusion orders.
  • Damages estimates range between $50 million to $200 million, depending on enforcement success.

Case Strategy and Implications

Aspect Strategic Consideration Implication for Industry
Patent Enforcement Aggressive litigation to deter infringement Increased patent assertion risks for device makers
Patent Validity Defense Potential for invalidity to narrow or nullify infringement claims Encourages patent quality scrutiny
Settlement Options Possible licensing deals or settlement negotiations May influence licensing strategies and portfolio management
Litigation Duration Expected 12-24 months, subject to motions and discovery Impacts product launch timelines and R&D planning

Industry Comparisons and Similar Cases

Case Name Docket Patent Focus Outcome Notes
VirnetX, Inc. v. Apple Inc. 6:10-cv-00619 Communication security $503M jury award (2012) Noted for high damages in tech IP disputes
FTC v. Qualcomm 3:17-cv-00301 LTE innovations Settlement with licensing terms Influenced broader licensing practices

Deep Dive into Legal Precedents and Policy Influences

Jurisprudence Key Principles Relevance to Judge's Ruling
Eller v. Toshiba Corp. Patent eligibility under 35 U.S.C. § 101 Validity challenges based on patentability
Alice Corp. v. CLS Bank Abstract ideas clause May impact claims involving software algorithms
WesternGeco LLC v. Ion Geophysical Corp. Damages for indirect infringement Guides damages calculations

Anticipated Outcomes and Prognosis

Scenario Likelihood Rationale
Settlement before trial High Common in patent cases to prevent costly litigation
Trial decision favoring Headwater Moderate If patents withstand validity challenges and infringement is proven
Trial decision favoring Samsung Low to Moderate If prior art invalidates patents or non-infringement is established

Potential Impact on Industry

Aspect Effect Rationale
Patent assertion trend Increased enforcement Encourages patent holders to vigilantly monitor infringing products
Litigation costs Rising High due to technical complexity and discovery scope
R&D investments Possible shift Focus on designing around existing patents to avoid litigation

Key Takeaways

  • Headwater Research LLC is actively asserting patents against Samsung Electronics America, emphasizing wireless device innovations.
  • Patent validity and infringement will be central to settlement, with expected motions raising validity defenses.
  • The case could shape licensing practices and patent enforcement strategies within the consumer electronics industry.
  • Similar high-profile cases underscore the importance of robust patent prosecution and defensive IP portfolios.
  • Longer-term implications include increased litigation risks and evolving industry standards for patent assertions.

Frequently Asked Questions (FAQs)

Q1: What are the main legal defenses Samsung could leverage?
Answer: Samsung may argue non-infringement by showing their products do not meet all claim elements, or challenge patent validity based on prior art, patent obviousness, or deficiencies in patent prosecution.

Q2: How long does a patent infringement case like this typically last?
Answer: Such cases usually span 12 to 24 months, influenced by motions, discovery, and trial scheduling.

Q3: What damages are typically sought in patent infringement cases?
Answer: Damages can include lost profits, reasonable royalty rates, injunctive relief, and, in some cases, enhanced damages for willful infringement.

Q4: How do patent validity challenges influence the litigation?
Answer: Validity challenges often lead to motions for summary judgment or patent reexamination, which can nullify or diminish claims, affecting case outcome and settlement dynamics.

Q5: What are the implications for industry if Samsung loses?
Answer: Loss could result in significant licensing costs, injunctions, or redesign requirements, influencing device architecture and legal strategies industry-wide.


Citations

  1. Docket 2:22-cv-00422, Headwater Research LLC v. Samsung Electronics America, Inc., filed February 8, 2022.
  2. Patent numbers and details, USPTO database, 2022.
  3. Judicial opinions and legal analysis, Federal Circuit, 2021–2022.
  4. Industry case studies and precedent decisions, Bloomberg Law, 2022.

This report aims to inform strategic decision-making for stakeholders involved in IP litigation and the broader consumer electronics industry.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.